Dorethe underlines, that the take-back pilot is not the only way, in
which we work to reuse or recycle plastic.
“We have a clear ambition to become a fully circular company, and therefore our commitment to playing our part in solving the world’s plastic challenge does not start and stop with insulin pens,” she says.
Dorethe explains that different kinds of plastic calls for different approaches.
“In 2019, we banned all single-used plastic not used for specific and relevant purposes within our R&D organisation or in production,” she says.
“But within production we also have another type of high-quality plastic waste which could easily be given a new life in all sorts of products. Since early 2000 we have been heavily invested in making sure that this happens wherever possible.”
According to Dorethe, this work is starting to bear fruit and our global production now recycles more than 90% of its waste.
“For a long time, we have been collecting plastic waste from our production, making sure that it is reused or recycled,” she says.
“But in the recent years we have seen a change in society towards a more sustainable mindset, which has allowed us to make demands on who we provide to, and that our plastic is used for sustainable products.”
“I think these are really exciting times, where we see a lot of companies and organisations coming together in finding solutions to problems that should be top of mind for all of us – how we take better care of our environment and create a more circular world.”